Executive summary: Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents

PeDRA Use of Retinoids in Ichthyosis Work Group

doi:10.1016/j.jaad.2021.08.047

Executive summary: Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents

PeDRA Use of Retinoids in Ichthyosis Work Group

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	158-161
Number of pages	4
Journal	Journal of the American Academy of Dermatology
Volume	86
Issue number	1
DOIs	https://doi.org/10.1016/j.jaad.2021.08.047
State	Published - Jan 2022

All Science Journal Classification (ASJC) codes

Dermatology

Access to Document

10.1016/j.jaad.2021.08.047

Cite this

@article{4bcdf2a11c734e6f99a460074e464762,

title = "Executive summary: Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents",

author = "{PeDRA Use of Retinoids in Ichthyosis Work Group} and Zaenglein, {Andrea L.} and Levy, {Moise L.} and Stefanko, {Nicole S.} and Benjamin, {Latanya T.} and Bruckner, {Anna L.} and Keith Choate and Craiglow, {Brittany G.} and DiGiovanna, {John J.} and Eichenfield, {Lawrence F.} and Peter Elias and Philip Fleckman and Lawley, {Leslie P.} and Lewis, {Richard A.} and Lucky, {Anne W.} and Mathes, {Erin F.} and Milstone, {Leonard M.} and Paller, {Amy S.} and Patel, {Sonali S.} and Siegel, {Dawn H.} and Joyce Teng and Tanumihardjo, {Sherry A.} and Lauren Thaxton and Williams, {Mary L.}",

note = "Funding Information: Funding sources: This project was funded by unrestricted educational grants from Sun Pharmaceuticals and the Foundation for Ichthyosis and Related Skin Types . Administrative support was provided by the Pediatric Dermatology Research Alliance . Funding Information: Dr Zaenglein is or has been an investigator for AbbVie, Incyte, Pfizer, Sun Pharmaceuticals; on the advisory board for Cassiopea and Verrica; a consultant for Pfizer and Sun Pharmaceuticals; Editor-in-Chief for Pediatric Dermatology; and an author for UptoDate. Dr Levy is or has been an investigator for Fibrocell, Galderma, Janssen, Pfizer; a consultant for Cassiopea, Regeneron, and UCB; on the advisory board for Cassiopea, Regeneron, and UCB; a section editor and author for UptoDate; and data and safety monitoring board for Novan. Dr Benjamin is or has been a consultant for Dove, Mustela, CeraVe, La Roche-Posay; on the advisory board for Mustela, CeraVe, La Roche-Posay, Bioderma, Cutanea, Biofrontera, Menlo Therapeutics, and Pfizer; on the speakers bureau for Regeneron and Sanofi-Genzyme, and an author for UptoDate. Dr Bruckner is or has been an investigator for Mayne Pharma. Dr Choate is or has been on the advisory board for AbbVie and Janssen; a speaker for Abbvie and Janssen; a consultant for Mayne Pharma and Timber Pharmaceuticals; an investigator for Mayne Pharma; and an author for UptoDate. Dr Craiglow is or has been on the advisory board for Aclaris, Arena Pharmaceuticals, and Pfizer; a consultant for Aclaris, Concert Pharmaceuticals, and Pfizer; and a speaker for Pfizer, Regeneron, and Sanofi-Genzyme. Dr Eichenfield is or has been an investigator for AbbVie, Galderma, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Verrica; a consultant for AbbVie, Galderma, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Verrica; on the advisory board for Cassiopea; and an author for UptoDate. Dr Lawley is or has been an author for UptoDate. Dr Mathes is or has been a consultant for Aldeyra Therapeutics, Rodan+Fields, and Pierre Fabre and an author for UptoDate. Dr Paller is or has been an investigator for AbbVie, Anaptysbio, Celgene, Castle Creek, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron and a consultant for Almirall, Amgen, Asana, Boehringer-Ingelheim, Castle Creek, Dermavant, Dermira, Exicure, Galderma, Lenus, Leo, MEDA Corp, Meiji Seika, Novan, Pfizer, and Regeneron, Sanofi-Genzyme, and Sol Gel. Dr Siegel is or has been a consultant for Arqule, an author for UptoDate, and has received a research grant from Sun Pharmaceuticals. Dr Tanumihardjo is or has been on an expert panel for the World Health Organization. Drs Stefanko, DiGiovanna, Elias, Fleckman, Lewis, Lucky, Milstone, Patel, Teng, Thaxton, and Williams have no conflicts of interest to declare. ",

year = "2022",

month = jan,

doi = "10.1016/j.jaad.2021.08.047",

language = "English (US)",

volume = "86",

pages = "158--161",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Executive summary

T2 - Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents

AU - PeDRA Use of Retinoids in Ichthyosis Work Group

AU - Zaenglein, Andrea L.

AU - Levy, Moise L.

AU - Stefanko, Nicole S.

AU - Benjamin, Latanya T.

AU - Bruckner, Anna L.

AU - Choate, Keith

AU - Craiglow, Brittany G.

AU - DiGiovanna, John J.

AU - Eichenfield, Lawrence F.

AU - Elias, Peter

AU - Fleckman, Philip

AU - Lawley, Leslie P.

AU - Lewis, Richard A.

AU - Lucky, Anne W.

AU - Mathes, Erin F.

AU - Milstone, Leonard M.

AU - Paller, Amy S.

AU - Patel, Sonali S.

AU - Siegel, Dawn H.

AU - Teng, Joyce

AU - Tanumihardjo, Sherry A.

AU - Thaxton, Lauren

AU - Williams, Mary L.

N1 - Funding Information: Funding sources: This project was funded by unrestricted educational grants from Sun Pharmaceuticals and the Foundation for Ichthyosis and Related Skin Types . Administrative support was provided by the Pediatric Dermatology Research Alliance . Funding Information: Dr Zaenglein is or has been an investigator for AbbVie, Incyte, Pfizer, Sun Pharmaceuticals; on the advisory board for Cassiopea and Verrica; a consultant for Pfizer and Sun Pharmaceuticals; Editor-in-Chief for Pediatric Dermatology; and an author for UptoDate. Dr Levy is or has been an investigator for Fibrocell, Galderma, Janssen, Pfizer; a consultant for Cassiopea, Regeneron, and UCB; on the advisory board for Cassiopea, Regeneron, and UCB; a section editor and author for UptoDate; and data and safety monitoring board for Novan. Dr Benjamin is or has been a consultant for Dove, Mustela, CeraVe, La Roche-Posay; on the advisory board for Mustela, CeraVe, La Roche-Posay, Bioderma, Cutanea, Biofrontera, Menlo Therapeutics, and Pfizer; on the speakers bureau for Regeneron and Sanofi-Genzyme, and an author for UptoDate. Dr Bruckner is or has been an investigator for Mayne Pharma. Dr Choate is or has been on the advisory board for AbbVie and Janssen; a speaker for Abbvie and Janssen; a consultant for Mayne Pharma and Timber Pharmaceuticals; an investigator for Mayne Pharma; and an author for UptoDate. Dr Craiglow is or has been on the advisory board for Aclaris, Arena Pharmaceuticals, and Pfizer; a consultant for Aclaris, Concert Pharmaceuticals, and Pfizer; and a speaker for Pfizer, Regeneron, and Sanofi-Genzyme. Dr Eichenfield is or has been an investigator for AbbVie, Galderma, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Verrica; a consultant for AbbVie, Galderma, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Verrica; on the advisory board for Cassiopea; and an author for UptoDate. Dr Lawley is or has been an author for UptoDate. Dr Mathes is or has been a consultant for Aldeyra Therapeutics, Rodan+Fields, and Pierre Fabre and an author for UptoDate. Dr Paller is or has been an investigator for AbbVie, Anaptysbio, Celgene, Castle Creek, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron and a consultant for Almirall, Amgen, Asana, Boehringer-Ingelheim, Castle Creek, Dermavant, Dermira, Exicure, Galderma, Lenus, Leo, MEDA Corp, Meiji Seika, Novan, Pfizer, and Regeneron, Sanofi-Genzyme, and Sol Gel. Dr Siegel is or has been a consultant for Arqule, an author for UptoDate, and has received a research grant from Sun Pharmaceuticals. Dr Tanumihardjo is or has been on an expert panel for the World Health Organization. Drs Stefanko, DiGiovanna, Elias, Fleckman, Lewis, Lucky, Milstone, Patel, Teng, Thaxton, and Williams have no conflicts of interest to declare.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85115389838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115389838&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2021.08.047

DO - 10.1016/j.jaad.2021.08.047

M3 - Article

C2 - 34499997

AN - SCOPUS:85115389838

SN - 0190-9622

VL - 86

SP - 158

EP - 161

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 1

ER -

Executive summary: Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this